InvestorsHub Logo
Followers 38
Posts 2100
Boards Moderated 0
Alias Born 09/06/2013

Re: None

Thursday, 10/10/2019 10:47:18 AM

Thursday, October 10, 2019 10:47:18 AM

Post# of 1242
NEWS...

Guardion(R) Announces Statistically Significant Blood Assay Study Results

Study Results Show 40 Times Higher Blood Concentration Levels of Mesozeaxanthin From Lumega-Z, Guardion's Flagship Medical Food, as compared to Standard AREDS2 Over-The-Counter Gel Caps

San Diego, California, Oct. 10, 2019 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. ("Guardion" or the "Company") (Nasdaq: GHSI) announced the formal results of a blood assay study that established that Lumega-Z, Guardion's proprietary medical food designed specifically to replenish and restore the eye's macular protective pigment, provided 40 times higher concentrations and bioavailability of mesozeaxanthin in the blood as compared to over-the-counter AREDS2 gel cap supplements.

The study was conducted by Professor Richard A. Bone, BSc, PhD, a member of the faculty of the Department of Physics at Florida International University in Miami, Florida. Dr. Bone is also a member of the Company's Scientific Advisory Board. Dr Bone was the first scientist to note the presence of mesozeaxanthin in the macular protective pigment and to suggest its importance in macular health. The study results are currently being prepared for publication in late 2019.

David Evans, PhD, Guardion's Chief Science Officer, commenting on this large disparity in the blood concentration levels resulting from the ingestion of Lumega-Z as compared to AREDS2 gel cap supplements, stated, "Considerable research demonstrates the importance of mesozeaxanthin for protecting the macular region of the retina and staving off vision loss due to macular degeneration. The results of this IRB-approved clinical study clearly show the potent nature of our proprietary formula and further explain the beneficial results observed and documented in patients with eye disease receiving Lumega-Z.

@Knowchit

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GHSI News